Cited by 394Gut microbiota and healthDialysis and Renal Disease ManagementGastrointestinal motility and disorders

Role of the Gut Microbiome in Uremia: A Potential Therapeutic Target

Open access
Ramezani, Ali, Massy, Ziad A., Meijers, Björn, Evenepoel, Pieter, Vanholder, Raymond, Raj, Dominic S.·2016·American Journal of Kidney Diseases

Abstract

Also known as the "second human genome," the gut microbiome plays important roles in both the maintenance of health and the pathogenesis of disease. The symbiotic relationship between host and microbiome is disturbed due to the proliferation of dysbiotic bacteria in patients with chronic kidney disease (CKD). Fermentation of protein and amino acids by gut bacteria generates excess amounts of potentially toxic compounds such as ammonia, amines, thiols, phenols, and indoles, but the generation of short-chain fatty acids is reduced. Impaired intestinal barrier function in patients with CKD permits translocation of gut-derived uremic toxins into the systemic circulation, contributing to the progression of CKD, cardiovascular disease, insulin resistance, and protein-energy wasting. The field of microbiome research is still nascent, but is evolving rapidly. Establishing symbiosis to treat uremic syndrome is a novel concept, but if proved effective, it will have a significant impact on the management of patients with CKD.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1053/j.ajkd.2015.09.027

Cites

163 of 163 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

2 of the 165 references couldn’t be matched to a known paper.

Research works printed but not linked: 9

  1. [96]Ringoir S Vanholder R Massy Z Proceedings of the Ghent Symposium on Uremic Toxins Advances in Experimental Medicine and Biology 1986 223 59 67
  2. [113]Freudenberg MA Tchaptchet S Keck S Lipopolysaccharide sensing an important factor in the innate immune response to Gram-negative bacterial infections: benefits and hazards of LPS hypersensitivity Immunobiology 2008 213 3–4 193 203 18406367
  3. [152]Watanabe H Miyamoto Y Honda D p-Cresyl sulfate causes renal tubular cell damage by inducing oxidative stress by activation of NADPH oxidase Kidney Int 2013 83 4 582 592 23325087
  4. [155]Wong J Piceno YM Desantis TZ Pahl M Andersen GL Vaziri ND Expansion of urease- and uricase-containing, indole- and p-cresol-forming and contraction of short-chain fatty acid-producing intestinal microbiota in ESRD Am J Nephrol 2014 39 3 230 237 24643131 PMC4049264
  5. [160]Campbell RA Grettie DP Bartos F Bartos D Marton LJ Uremic polyamine dysmetabolism Proc Clin Dial Transplant Forum 1978 8 194 198 756045
  6. [161]Igarashi K Ueda S Yoshida K Kashiwagi K Polyamines in renal failure Amino Acids 2006 31 4 477 483 16554974
  7. [162]Kushner D Beckman B Nguyen L Polyamines in the anemia of end-stage renal disease Kidney Int 1991 39 4 725 732 2051730
  8. [166]Dou L Bertrand E Cerini C The uremic solutes p-cresol and indoxyl sulfate inhibit endothelial proliferation and wound repair Kidney Int 2004 65 2 442 451 14717914
  9. [167]Nakabayashi I Nakamura M Kawakami K Effects of synbiotic treatment on serum level of p-cresol in haemodialysis patients: a preliminary study Nephrol Dial Transplant 2011 26 3 1094 1098 20929916

Cited by

Sorted by citations

Authors
Ramezani, A., Massy, Z. A., Meijers, B., Evenepoel, P., Vanholder, R., & Raj, D. S.
Affiliations
  • George Washington University (US)
  • Inserm (FR)
  • Universitair Ziekenhuis Leuven (BE)
  • Ghent University Hospital (BE)
Corresponding author
Raj, Dominic S.
Venue
American Journal of Kidney Diseases
Publisher
Elsevier BV
Published
2016-03
Volume
67
Issue
3
Pages
483-498
ISSN
0272-6386 (ISSN-L)
OpenAlex
W2180350916
Cited by
394
References
165
Citations by year
2026: 27 · 2025: 39 · 2024: 46 · 2023: 37 · 2022: 45 · 2021: 41 · 2020: 45 · 2019: 45 · 2018: 30 · 2017: 29 · 2016: 8 · 2015: 1
FWCI
2.20
Type
journal article
Language
en
Open access
Locations
  • American Journal of Kidney Diseases (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • Ghent University Academic Bibliography (Ghent University) (submittedVersion)
  • Lirias (KU Leuven) (submittedVersion)
Funders
National Institutes of Health (1R01DK073665-01A1, 1U01DK099924-01, 1U01DK099914-01)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Medicine › Nephrology › Dialysis and Renal Disease Management
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
Keywords
gut microbiota, uremia, chronic kidney disease, uremic toxins, dysbiosis, intestinal barrier dysfunction, short-chain fatty acids, protein fermentation, microbial translocation, cardiovascular disease, insulin resistance, protein-energy wasting, microbiota-based therapy
MeSH terms
Gastrointestinal Microbiome, Humans, Uremia, Disease Progression, Renal Insufficiency, Chronic, Early Medical Intervention, Dysbiosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review